Ad is loading...
CWGCX
Price
$67.30
Change
+$0.23 (+0.34%)
Updated
Nov 22 closing price
GCEYX
Price
$17.76
Change
+$0.05 (+0.28%)
Updated
Nov 22 closing price
Ad is loading...

CWGCX vs GCEYX

Header iconCWGCX vs GCEYX Comparison
Open Charts CWGCX vs GCEYXBanner chart's image
American Funds Capital World Gr&Inc C
Price$67.30
Change+$0.23 (+0.34%)
VolumeN/A
CapitalizationN/A
AB Global Core Equity Advisor
Price$17.76
Change+$0.05 (+0.28%)
VolumeN/A
CapitalizationN/A
CWGCX vs GCEYX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CWGCX vs. GCEYX commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CWGCX is a StrongBuy and GCEYX is a Buy.

FUNDAMENTALS
Fundamentals
CWGCX has more cash in the bank: 126B vs. GCEYX (2.91B). CWGCX pays higher dividends than GCEYX: CWGCX (1.04) vs GCEYX (0.99). CWGCX was incepted earlier than GCEYX: CWGCX (24 years) vs GCEYX (10 years). GCEYX is a more actively managed with annual turnover of: 48.00 vs. CWGCX (27.00). GCEYX has a lower initial minimum investment than CWGCX: GCEYX (0) vs CWGCX (250). GCEYX (18.57) and CWGCX (17.95) have marching annual gain over last year. CWGCX return over 5 years is better than : 37.99 vs. GCEYX (31.23).
CWGCXGCEYXCWGCX / GCEYX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years10 years-
Gain YTD13.58412.803106%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets126B2.91B4,325%
Annual Yield % from dividends1.040.99105%
Returns for 1 year17.9518.5797%
Returns for 3 years4.551.26362%
Returns for 5 years37.9931.23122%
Returns for 10 years46.4481.9957%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CTRA27.440.61
+2.27%
Coterra Energy
USNA39.36-0.16
-0.40%
USANA Health Sciences
RDNT81.30-0.86
-1.05%
RadNet
AXDX1.67-0.03
-1.76%
Accelerate Diagnostics
TCRX3.94-0.18
-4.37%
TScan Therapeutics